Department of Pharmacology & Clinical Pharmacology, University of Auckland, New Zealand.
J Pharm Sci. 2013 Sep;102(9):2941-52. doi: 10.1002/jps.23574. Epub 2013 May 6.
The pharmacokinetic behavior of medicines used in humans follows largely predictable patterns across the human age range from premature babies to elderly adults. Most of the differences associated with age are in fact due to differences in size. Additional considerations are required to describe the processes of maturation of clearance processes and postnatal changes in body composition. Application of standard approaches to reporting pharmacokinetic parameters is essential for comparative human pharmacokinetic studies from babies to adults. A standardized comparison of pharmacokinetic parameters obtained in children and adults is shown for 46 drugs. Appropriate size scaling shows that children (over 2 years old) are similar to adults. Maturation changes are generally completed within the first 2 years of postnatal life; consequently babies may be considered as immature children, whereas children are just small adults.
人类应用药物的药代动力学行为在从早产儿到老年人的整个年龄段内呈现出高度可预测的模式。与年龄相关的大多数差异实际上是由于个体大小的差异所致。为了描述清除过程的成熟和出生后身体成分的变化,还需要考虑其他因素。应用标准方法报告药代动力学参数对于从婴儿到成人的比较人体药代动力学研究至关重要。本文对 46 种药物在儿童和成人中获得的药代动力学参数进行了标准化比较。适当的体表面积标化表明,2 岁以上的儿童与成人相似。成熟变化通常在出生后 2 年内完成;因此,婴儿可以被视为不成熟的儿童,而儿童只是小大人。